Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

ProPhase Labs Common Stock Net 2010-2025 | PRPH

ProPhase Labs common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
  
ProPhase Labs Annual Common Stock Net
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
ProPhase Labs Quarterly Common Stock Net
(Millions of US $)
2025-03-31 $0
2024-12-31 $0
2024-09-30 $0
2024-06-30 $0
2024-03-31 $0
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2012-03-31 $0
2011-12-31 $0
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $0
2009-03-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.012B $0.007B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $67.532B 25.98
Zoetis (ZTS) United States $66.043B 23.96
Daiichi Sankyo, - (DSNKY) Japan $46.279B 23.72
Takeda Pharmaceutical (TAK) Japan $45.915B 9.37
BeOne Medicines - (ONC) Switzerland $31.757B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.520B 0.00
Summit Therapeutics (SMMT) United States $20.980B 0.00
Merck (MKKGY) Germany $16.285B 10.59
Shionogi (SGIOY) Japan $15.227B 15.26
United Therapeutics (UTHR) United States $13.551B 11.73
Neurocrine Biosciences (NBIX) United States $12.297B 36.68
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.413B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.760B 0.00
Corcept Therapeutics (CORT) United States $7.584B 63.69
Grifols, S.A (GRFS) Spain $7.288B 0.00
Stevanato Group S.p.A (STVN) Italy $6.617B 39.02
Ionis Pharmaceuticals (IONS) United States $6.510B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.558B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.771B 13.19
NewAmsterdam Pharma (NAMS) Netherlands $2.736B 0.00
Hypermarcas (HYPMY) Brazil $2.725B 20.49
Crinetics Pharmaceuticals (CRNX) United States $2.579B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.409B 8.07
Centessa Pharmaceuticals (CNTA) United Kingdom $2.219B 0.00
Ocular Therapeutix (OCUL) United States $2.185B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.721B 0.00
ARS Pharmaceuticals (SPRY) United States $1.609B 0.00
Dyne Therapeutics (DYN) United States $1.599B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.505B 22.41
Evotec AG (EVO) Germany $1.353B 0.00
Ardelyx (ARDX) United States $1.301B 0.00
Guardian Pharmacy Services (GRDN) United States $1.258B 0.00
Harrow (HROW) United States $1.238B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.237B 0.00
Xeris Biopharma Holdings (XERS) United States $1.163B 0.00
Collegium Pharmaceutical (COLL) United States $1.138B 6.22
Cronos Group (CRON) Canada $1.025B 0.00
Enliven Therapeutics (ELVN) United States $0.889B 0.00
Akebia Therapeutics (AKBA) United States $0.888B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.697B 0.00
Siga Technologies (SIGA) United States $0.679B 8.39
ProKidney (PROK) United States $0.660B 0.00
Zevra Therapeutics (ZVRA) United States $0.640B 0.00
KalVista Pharmaceuticals (KALV) United States $0.625B 0.00
Elite Pharmaceuticals (ELTP) United States $0.610B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.600B 6.18
Organogenesis (ORGO) United States $0.585B 0.00
Theravance Biopharma (TBPH) United States $0.570B 0.00
Bioventus (BVS) United States $0.569B 13.86
Relay Therapeutics (RLAY) United States $0.560B 0.00
Tourmaline Bio (TRML) United States $0.539B 0.00
USANA Health Sciences (USNA) United States $0.536B 10.98
Xencor (XNCR) United States $0.499B 0.00
Oruka Therapeutics (ORKA) United States $0.489B 0.00
Savara (SVRA) United States $0.467B 0.00
Aquestive Therapeutics (AQST) United States $0.383B 0.00
Esperion Therapeutics (ESPR) United States $0.366B 0.00
Nanobiotix S.A (NBTX) France $0.352B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.331B 0.00
Aldeyra Therapeutics (ALDX) United States $0.314B 0.00
AleAnna (ANNA) United States $0.313B 0.00
Larimar Therapeutics (LRMR) United States $0.313B 0.00
Nature's Sunshine Products (NATR) United States $0.284B 18.51
Nektar Therapeutics (NKTR) United States $0.279B 0.00
Altimmune (ALT) United States $0.274B 0.00
4D Molecular Therapeutics (FDMT) United States $0.256B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
OmniAb (OABI) United States $0.239B 0.00
MediWound (MDWD) Israel $0.202B 0.00
Heron Therapeutics (HRTX) United States $0.196B 0.00
China SXT Pharmaceuticals (SXTC) China $0.184B 0.00
Journey Medical (DERM) United States $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.178B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Profound Medical (PROF) Canada $0.169B 0.00
Lyell Immunopharma (LYEL) United States $0.164B 0.00
MEI Pharma (MEIP) United States $0.156B 0.00
Lexeo Therapeutics (LXEO) United States $0.147B 0.00
Korro Bio (KRRO) United States $0.141B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.135B 20.91
Avita Medical (RCEL) United States $0.128B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Avalo Therapeutics (AVTX) United States $0.118B 0.00
Liminatus Pharma (LIMN) United States $0.117B 0.00
Inhibikase Therapeutics (IKT) United States $0.112B 0.00
Cassava Sciences (SAVA) United States $0.109B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.088B 19.94
Surrozen (SRZN) United States $0.086B 0.00
Cardiol Therapeutics (CRDL) Canada $0.085B 0.00
Achieve Life Sciences (ACHV) Canada $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.085B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
BioNxt Solutions (BNXTF) Canada $0.080B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
Nutriband (NTRB) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Metagenomi (MGX) United States $0.068B 0.00
Pyxis Oncology (PYXS) United States $0.064B 0.00
Inotiv (NOTV) United States $0.064B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.062B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
DURECT (DRRX) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.057B 0.00
Wellgistics Health (WGRX) United States $0.056B 0.00
PolyPid (PYPD) Israel $0.051B 0.00
Unicycive Therapeutics (UNCY) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.042B 25.82
Plus Therapeutics (PSTV) United States $0.042B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.038B 0.00
Enlivex Therapeutics (ENLV) Israel $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
FibroGen (FGEN) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Karyopharm Therapeutics (KPTI) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Tempest Therapeutics (TPST) United States $0.030B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Mural Oncology (MURA) Ireland $0.027B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Cosmos Health (COSM) United States $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.021B 0.00
CASI Pharmaceuticals (CASI) China $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.019B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Ainos (AIMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Incannex Healthcare (IXHL) Australia $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
BioVie (BIVI) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.52
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00